Life sciences · Journal article
Biomolecules · November 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Oral diseases have affected a large population worldwide. Phytochemicals have shown antioxidant, antibacterial, and anti-cancer properties, suggesting their potential for managing oral diseases. Conventional dosage forms containing phytochemicals are commercially available and have demonstrated promising effects in oral conditions. Recently, numerous phytochemical-based novel delivery systems (liposomes, niosomes, nanoparticles, nanofibers, hydrogels, etc.) have also been prepared to improve the efficacy of phytochemicals in managing the conditions discussed here. These novel delivery systems can improve local retention, protect phytochemicals from degradation, enhance penetration and bioavailability, and provide controlled or sustained release. This review therefore offers a delivery-system-focused perspective. Research articles from 2013 to 2026 were systematically reviewed. Preclinical and clinical applications of phenolic compounds (catechins, curcumin, quercetin, and resveratrol), carotenoids (lycopene, astaxanthin, and β-carotene), and alkaloids (berberine and piperine) for managing periodontal diseases, oral cancers, potentially malignant oral disorders, dental caries, oral candidiasis, and oral ulcers are summarized. The article provides an overview of oral diseases, classification, common phytochemicals, mechanisms, and clinical improvements. Finally, conventional and novel drug delivery systems loaded with phytochemicals are discussed. This work explores challenges and outlines future directions, with special attention to the role of artificial intelligence.